Skip to main content
Madrigal

Senior Director, Clinical Supply Release

RemoteUnited States only
Published
Role
Operations
Experience
Senior
Employment
Full-time
$244.6k–$299k/yr
Check eligibility

Open to US only. Set where you work from to check your eligibility.

No BS summary

Senior Director owning QA disposition and release of clinical supplies for a biopharma company. Requires 15+ years GMP QA/release experience (clinical supply strongly relevant), BS+ in Science/Engineering, strong documentation discipline, and 20-30% travel. US-based remote role.

Core skills

Veeva Vault Quality (eQMS)

What you'll do

  • Own release criteria, checklists, and documentation standards, ensure consistent, compliant disposition decisions
  • Drive cycle-time and right-first-time improvements for clinical release workflows
  • Produce deliverables such as release checklists, release dashboards, and clinical release cycle-time reports
  • Ensure QA oversight over clinical packaging runs
  • Coordinate deviations / investigations / change controls impacting release timelines, ensure timely risk assessments and action closure
  • Partner with Clinical Ops / Supply Chain on release schedules, priorities, and mitigation plans
  • Produce deliverables such as release risk summaries, issue / action logs, and escalation briefs
  • Maintain audit-ready release documentation and evidence packages, support GxP inspections
  • Oversee external clinical vendors as applicable and ensure compliance with labelling / packaging expectations
  • Produce deliverables such as inspection-ready evidence indexes and vendor oversight packs

What they require

  • BS+ Science / Engineering (or related)
  • 15+ years GMP QA / release experience (clinical supply experience strongly relevant)
  • Strong documentation discipline and cross-functional coordination capability
  • Ability to travel 20-30%, both domestic and international
  • Experience in pharmaceutical / biotech clinical supply chains, IMP labelling / packaging, and external clinical vendors (preferred)
  • Experience supporting GxP inspections involving clinical supply release activities (preferred)

Benefits

  • All full-time employees receive equity
  • Flexible paid time off
  • Medical, dental, vision and life/disability insurance
  • 401(k) offerings (i.e., traditional, Roth, and employer match)
  • Additional voluntary benefits like supplemental life insurance, legal services, and other offerings
  • Mental health benefits through our Employee Assistance Program for employees and their family

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH. Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).

BiopharmaMid-size
$244.6k–$299k/yr